Remdesivir for the Treatment of Covid-19 — Preliminary Report

Remdesivir for the Treatment of Covid-19 — Preliminary Report – New England Journal of Medicine

Commentaries: Preliminary report on NIAID trial of remdesivir – PulmCrit AND Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery – National Institutes of Health AND Covid-19 study details benefits of treatment with remdesivir, and also its limitations – STAT

Related Commentary on Twitter (Thread – Click for more)

I finished reading the Remdesivir trial

If you want my thoughts you will have to read this thread

[Thread] pic.twitter.com/GqA30lCOLI

— Vinay Prasad (@VPrasadMDMPH) May 23, 2020